Chugai Pharmaceutical Co Ltd (CHGCF)
33.27
0.00 (0.00%)
USD |
OTCM |
Apr 15, 16:00
Chugai Pharmaceutical Total Return Price: 33.27 for April 15, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| April 15, 2024 | 33.27 |
| April 12, 2024 | 33.27 |
| April 11, 2024 | 39.14 |
| April 10, 2024 | 39.14 |
| April 09, 2024 | 39.14 |
| April 08, 2024 | 39.14 |
| April 05, 2024 | 39.14 |
| April 04, 2024 | 39.14 |
| April 03, 2024 | 39.14 |
| April 02, 2024 | 39.14 |
| April 01, 2024 | 39.14 |
| March 28, 2024 | 39.14 |
| March 27, 2024 | 39.14 |
| March 26, 2024 | 39.14 |
| March 25, 2024 | 39.14 |
| March 22, 2024 | 39.14 |
| March 21, 2024 | 39.14 |
| March 20, 2024 | 41.56 |
| March 19, 2024 | 41.56 |
| March 18, 2024 | 41.56 |
| March 15, 2024 | 41.56 |
| March 14, 2024 | 41.56 |
| March 13, 2024 | 42.50 |
| March 12, 2024 | 43.72 |
| March 11, 2024 | 43.72 |
| Date | Value |
|---|---|
| March 08, 2024 | 43.72 |
| March 07, 2024 | 43.72 |
| March 06, 2024 | 39.99 |
| March 05, 2024 | 39.99 |
| March 04, 2024 | 39.99 |
| March 01, 2024 | 39.99 |
| February 29, 2024 | 39.99 |
| February 28, 2024 | 39.99 |
| February 27, 2024 | 35.06 |
| February 26, 2024 | 35.06 |
| February 23, 2024 | 35.06 |
| February 22, 2024 | 35.06 |
| February 21, 2024 | 35.06 |
| February 20, 2024 | 35.06 |
| February 16, 2024 | 35.06 |
| February 15, 2024 | 35.06 |
| February 14, 2024 | 35.06 |
| February 13, 2024 | 35.06 |
| February 12, 2024 | 35.06 |
| February 09, 2024 | 35.06 |
| February 08, 2024 | 35.06 |
| February 07, 2024 | 35.06 |
| February 06, 2024 | 37.00 |
| February 05, 2024 | 37.00 |
| February 02, 2024 | 37.00 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
19.61
Minimum
May 02 2019
50.81
Maximum
Jul 06 2020
31.21
Average
30.49
Median
Mar 09 2022
Total Return Price Benchmarks
| Takeda Pharmaceutical Co Ltd | 13.26 |
| Nxera Pharma Co Ltd | 9.72 |
| PeptiDream Inc | 9.50 |
| Stemcell Holdings Inc | 0.06 |